Prescription drug · NDA AUTHORIZED GENERIC
Sulfasalazine NDC 70518-1829
Sulfasalazine 500 mg/1 · Tablet · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-1829-3 | 7051818290370518182903 | 30 TABLET in 1 BLISTER PACK (70518-1829-3)Marketed from Oct 29, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sulfasalazine
- Generic name (nonproprietary)
- sulfasalazine
- Active ingredients
- Sulfasalazine — 500 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 007073
- Marketing start
- Listing expires
- Other FDA classes
- Aminosalicylic Acids (Chemical structure)
- Identifiers
- Product ID 70518-1829_5c3d4afb-989c-3f2a-e063-6394a90a34a8SPL ID 5c3d4afb-989c-3f2a-e063-6394a90a34a8
- Pharmacologic class
- Aminosalicylate
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518182903followed by a unit qualifier and the quantityPackage 70518-1829-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70518-1829
- What is NDC 70518-1829?
- 70518-1829 is the product NDC for Sulfasalazine, Sulfasalazine 500 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sulfasalazine.
- What is the active ingredient?
- Sulfasalazine.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sulfasalazine?
- 11 other product NDCs are listed under this name. See all Sulfasalazine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Sulfasalazine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Sulfasalazine | Sulfasalazine 500 mg/1 | Tablet, Delayed releaseOral | Sunrise Pharmaceutical, Inc. | 11534-201 | 11534-0201-0111534-0201-07 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-261 | 16571-0261-0116571-0261-30 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Sunrise Pharmaceutical, Inc. | 11534-200 | 11534-0200-0111534-0200-0411534-0200-07 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-3234 | 00093-3234-0100093-3234-0500093-3234-10 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-9715 | 63629-9715-01 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | Tablet, Delayed releaseOral | Mylan Pharmaceuticals Inc. | 59762-0104 | 59762-0104-0559762-0104-06 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | A-S Medication Solutions | 50090-0086 | 50090-0086-04 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | A-S Medication Solutions | 50090-6936 | 50090-6936-00 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-5000 | 59762-5000-0559762-5000-06 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-706 | 71610-0706-7071610-0706-80 |
Other NDCs under NDA 007073
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Azulfidinesulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 0013-0101 |
| Azulfidine EN-tabssulfasalazine | Sulfasalazine 500 mg/1 | Tablet, Delayed releaseOral | Pfizer Laboratories Div Pfizer Inc | 0013-0102 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | A-S Medication Solutions | 50090-0086 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | A-S Medication Solutions | 50090-6936 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | Tablet, Delayed releaseOral | Mylan Pharmaceuticals Inc. | 59762-0104 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-5000 |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-706 |